洲明科技(300232.SZ):第一期事業合夥人持股計劃已累計買入3805.7989萬股
格隆匯7月15日丨洲明科技(300232.SZ)公佈,截至公吿披露日,公司第一期事業合夥人持股計劃“深圳澤源私募證券基金管理有限公司-澤源利旺田13號私募證券投資基金”(“私募基金”)已通過二級市場購買(包含大宗交易以及競價交易)的方式累計買入公司股票3805.7989萬股,佔公司剔除回購股份後總股本的3.49%,成交金額約24052萬元(含交易税費),成交均價約6.32元/股。
截至公吿披露日,公司已完成第一期事業合夥人持股計劃標的股票的購買。該持股計劃購買的公司股票將按照規定予以鎖定,鎖定期為12個月,自最後一筆標的股票過户至私募基金之日起計算,即自2022年7月15日起至2023年7月14日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.